Legend Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-33
Closed -$2.29K 212
2023
Q1
$2.29K Hold
33
﹤0.01% 208
2022
Q4
$2.37K Hold
33
﹤0.01% 216
2022
Q3
$2.35K Buy
+33
New +$2.39K ﹤0.01% 204

Other funds holding BMY

Legend Financial Advisors's BMY Position: Q2 2023 in Review

Legend Financial Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 33 shares — an estimated $2.29K sold.

Legend Financial Advisors first reported a position in BMY in Q3 2022 and held it in 3 quarters. The position peaked at $2.37K in Q4 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Legend Financial Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Legend Financial Advisors sold 33 Bristol-Myers Squibb shares in Q2 2023, an estimated $2.29K.
  • Legend Financial Advisors first reported a position in Bristol-Myers Squibb in Q3 2022 and held it in 3 quarters.
  • Legend Financial Advisors's Bristol-Myers Squibb position peaked at $2.37K in Q4 2022.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Legend Financial Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.